Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

Document And Entity Information - shares
6 Months Ended
Jun. 30, 2022
Aug. 12, 2022
Document Information Line Items    
Entity Registrant Name ADIAL PHARMACEUTICALS, INC.  
Trading Symbol ADIL  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   25,853,962
Amendment Flag false  
Entity Central Index Key 0001513525  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Jun. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-38323  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 82-3074668  
Entity Address, Address Line One 1180 Seminole Trail  
Entity Address, Address Line Two Suite 495  
Entity Address, City or Town Charlottesville  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 22901  
City Area Code (434)  
Local Phone Number 422-9800  
Title of 12(b) Security Common Stock  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes